These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19602331)

  • 1. Management of hypertension in hemodialysis patients.
    Ram CV; Fenves AZ
    Curr Hypertens Rep; 2009 Aug; 11(4):292-8. PubMed ID: 19602331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive Hemodialysis, Blood Pressure, and Antihypertensive Medication Use.
    Bakris GL; Burkart JM; Weinhandl ED; McCullough PA; Kraus MA
    Am J Kidney Dis; 2016 Nov; 68(5S1):S15-S23. PubMed ID: 27772639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodialysis-associated hypertension: pathophysiology and therapy.
    Hörl MP; Hörl WH
    Am J Kidney Dis; 2002 Feb; 39(2):227-44. PubMed ID: 11840363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term antihypertensive effects of aliskiren, a direct renin inhibitor, in chronic hemodialysis patients.
    Ishimitsu T; Ohta S; Ohno E; Takahashi T; Numabe A; Okamura A; Ohba S; Hashimoto A; Matsuoka H
    Ther Apher Dial; 2013 Oct; 17(5):524-31. PubMed ID: 24107281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equal levels of blood pressure control in ESRD patients receiving high-efficiency hemodialysis and conventional hemodialysis.
    Velasquez MT; von Albertini B; Lew SQ; Mishkin GJ; Bosch JP
    Am J Kidney Dis; 1998 Apr; 31(4):618-23. PubMed ID: 9531177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive agents in hemodialysis patients: a current perspective.
    Inrig JK
    Semin Dial; 2010; 23(3):290-7. PubMed ID: 20374548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistant hypertension in dialysis.
    Symonides B; Lewandowski J; Małyszko J
    Nephrol Dial Transplant; 2023 Aug; 38(9):1952-1959. PubMed ID: 36898677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Arteriovenous Fistula Creation on Systolic and Diastolic Blood Pressure in Patients With Pre-dialysis Advanced Chronic Kidney Disease.
    Mathew RO; Fleg J; Rangaswami J; Cai B; Asif A; Sidhu MS; Bangalore S
    Am J Hypertens; 2019 Aug; 32(9):858-867. PubMed ID: 31150056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension in chronic dialysis patients: pathophysiology, monitoring, and treatment.
    Morse SA; Dang A; Thakur V; Zhang R; Reisin E
    Am J Med Sci; 2003 Apr; 325(4):194-201. PubMed ID: 12695724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease.
    Sica DA; Gehr TW; Fernandez A
    Drug Saf; 2000 May; 22(5):350-60. PubMed ID: 10830252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis.
    Scalise F; Sole A; Singh G; Sorropago A; Sorropago G; Ballabeni C; Maccario M; Vettoretti S; Grassi G; Mancia G
    J Hypertens; 2020 May; 38(5):936-942. PubMed ID: 31990900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension.
    Morishita Y; Hanawa S; Chinda J; Iimura O; Tsunematsu S; Kusano E
    Hypertens Res; 2011 Mar; 34(3):308-13. PubMed ID: 21124333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH).
    Sarafidis PA; Persu A; Agarwal R; Burnier M; de Leeuw P; Ferro CJ; Halimi JM; Heine GH; Jadoul M; Jarraya F; Kanbay M; Mallamaci F; Mark PB; Ortiz A; Parati G; Pontremoli R; Rossignol P; Ruilope L; Van der Niepen P; Vanholder R; Verhaar MC; Wiecek A; Wuerzner G; London GM; Zoccali C
    Nephrol Dial Transplant; 2017 Apr; 32(4):620-640. PubMed ID: 28340239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of renin-angiotensin system inhibitor on residual glomerular filtration rate in hemodialysis patients.
    Itoh Y; Fujikawa T; Toya Y; Mitsuhashi H; Kobayashi N; Ohnishi T; Tamura K; Hirawa N; Yasuda G; Umemura S
    Ther Apher Dial; 2012 Dec; 16(6):554-9. PubMed ID: 23190515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncertainties in BP management in dialysis patients.
    Doulton TWR; Swift PA; Murtaza A; Dasgupta I
    Semin Dial; 2020 May; 33(3):223-235. PubMed ID: 32285984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients.
    Gross E; Rothstein M; Dombek S; Juknis HI
    Am J Kidney Dis; 2005 Jul; 46(1):94-101. PubMed ID: 15983962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive Agents in the Dialysis Patient.
    Fravel MA; Bald E; Fraer M
    Curr Hypertens Rep; 2019 Jan; 21(1):5. PubMed ID: 30659374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension in pediatric long-term hemodialysis patients in the United States.
    Chavers BM; Solid CA; Daniels FX; Chen SC; Collins AJ; Frankenfield DL; Herzog CA
    Clin J Am Soc Nephrol; 2009 Aug; 4(8):1363-9. PubMed ID: 19556378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Challenges of Blood Pressure Control in Dialysis Patients.
    Campese VM; Lakdawala R
    Recent Adv Cardiovasc Drug Discov; 2015; 10(1):34-59. PubMed ID: 26567722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices.
    Shafi T; Sozio SM; Luly J; Bandeen-Roche KJ; St Peter WL; Ephraim PL; McDermott A; Herzog CA; Crews DC; Scialla JJ; Tangri N; Miskulin DC; Michels WM; Jaar BG; Zager PG; Meyer KB; Wu AW; Boulware LE;
    Medicine (Baltimore); 2017 Feb; 96(5):e5924. PubMed ID: 28151871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.